vedo | 13687

Vedolizumab (Entyvio®), level and antibodies

Keywords

Entyvio

Material

Serum
Serum gel tube, golden (1)

Min. quantity

1 mL

Stability

4 days / 18-25°C; 4 weeks / 2-8°C; 1 year / -20°C

Duration

1 - 2 weeks

Frequency

1 x per week

Price

CHF 213.30

Tariff

213.30 TP

Designation

see single analyses

Single analyses

Vedolizumab (Entyvio®), Antikörper vedak Serum	vedak	Serum
Vedolizumab (Entyvio®), Spiegel vedsp Serum	vedsp	Serum

Team of consultants

Dr. sc. nat. ETH, FAMH Specialist in laboratory medicine, main fields medical microbiology, immunology Diana Ciardo Head of Immunology / Infectious Disease Serology	Head of Immunology / Infectious Disease Serology	T +41 61 486 14 45
MSc Infection Biology Siro Ellenberger Candidate FAMH Specialist in laboratory medicine, main field immunology	Candidate FAMH Specialist in laboratory medicine, main field immunology	T +41 61 486 14 23
PhD Maurus Curti FAMH Specialist in laboratory medicine	FAMH Specialist in laboratory medicine	T +41 61 486 14 75
Dr. sc. nat. Corinne Ruppen FAMH Specialist in laboratory medicine, main field clinical chemistry	FAMH Specialist in laboratory medicine, main field clinical chemistry	T +41 61 486 13 67